# Presentation: 447579

## Dietary Supplement Research Centers: Botanicals

- <date/time>

**Dietary Supplement Research Centers: Botanicals**
**RFA OD-04-002 **** **
**     **

***Applicant Information Meeting***
***February 6, 2004***
***Bethesda MD***
**Christine A. Swanson, Ph.D.**
**Office of Dietary Supplements, NIH**
**swansonc@od.nih.gov**

## Overview

**  ****Dietary Supplement Research Centers**
** ****Botanical Research Center Program**
**  ****Expert Panel Review**
**NIH Presentation to Panel**
**Panel Recommendations**
**  ****RFA OD-04-002****	****	****	****	****	**** **
**New Features**
**Guidance Documents**

##   Congressional Mandate      (FY 1999)

***  ***Congressional Mandate      (FY 1999)

**“ ****establish a botanical research initiative with major research institutions in the United States”**

## Dietary Supplement Research Centers: Botanicals

_**Awards:**_
**University of California Los Angeles **
**University of Illinois at Chicago **
**University of Arizona **
**Purdue University/University of Alabama **
**University of Missouri **
**Iowa State University/University of Iowa **
_**Budget:**_** ****$1.0-1.5 Million/Year for 5 Years**
_**Awarding Organizations:**_
**ODS, NCCAM, NIEHS**
**Additional support from NIGMS, ORWH**

##  Presentation to Expert Panel February 21, 2003

## Botanical Research Centers Program 

_**Purpose**_**: To establish Specialized Research Centers  to investigate the biological effects of botanicals, including those available as ingredients in dietary supplements**
**  **

## Goals	

**To foster interdisciplinary research to promote rigorous scientific study of botanicals**
**To explore the potential of botanicals (dietary supplements) to improve health care**
**To develop models to evaluate the efficacy and safety of botanicals*********

*** ****Modified in RFA OD-04-002**

## Spectrum of Research Activities(Major Areas of Emphasis)

- <date/time>

**Spectrum of Research Activities****(Major Areas of Emphasis)**

**Identify and characterize botanicals**
**Assess bioavailability and bioactivity   **
**Identify active constituent****(s)**** and explore mechanism****(s)**** of action**
**Conduct clinical research **

## Required Elements	

**Institutional Commitment**
** ****Administrative Core**
*** *****Two Research Cores**
**Botanical Core Required**** ***
**Three to Four Research Projects**
**Pilot Research Program**
**Training and Career Development**** ***
**Consumer Information *******

*** ****Modified in RFA OD-04-002**

## Administrative

**Core**

**Research Projects**

**P1**

**P2**

**P3**

**RC 2**

**RC 3**

**Resource Cores**

**RC 1**

## Lessons Learned

**RFA**
**Required Elements Clearly Identified**
**The Grant Application**
**Scientific Merit (R01 Projects)**
**Research Experience of Investigators**
**Research Resources (Contemporary)**
**Collaborative Effort (Synergy) **
**Administrative Oversight**
**Administrative Core of Research Center**
**External Advisory Committee**
**NIH Program Staff**

## Questions to Expert Panel	

**Research Theme**
**Focus**
**Center Structure**
**Cores (Botany ?)**
**Synergy/Collaboration**
**Productivity**
**Criteria**

## Expert Panel Recommendations

**High-impact theme**
**Studies of basic mechanisms and human health, with a high level of translational interaction between the two**
**Innovative Technology**
******* Emphasis on quality assurance/quality control**

**http://nccam.nih.gov/training/centers/bot-research-index.htm**

## Guidance Document	

**NCCAM Policy on the Quality of Natural Products Research (see RFA)**
** **

**http://nccam.nih.gov/research/policies/natualproducts.htm**

## RFA OD-04-002

**RFA OD-04-002**
**Dietary Supplement Research Centers: Botanicals**

## RFA OD-04-002

**Developed in Collaboration with NIH Offices, Centers and Institutes (ODS, NCCAM, NIEHS) ***
**Important Dates**
**  ****Letter of Intent Receipt Date: May 18, 2004**
**  ****Application Receipt Date: June 15, 2004**
**  ****Peer Review Date: October/November 2004**
**  ****Council Review: January 2005 **
**  ****Earliest Anticipated Start Date: April 2005**

*** Other ICs may participate**

## Botanical (Definition)

**For the purpose of this RFA, “botanical” is defined as plants, plant parts (e.g., bark, leaves, stems, roots, flowers, fruits, seeds, berries),  plant exudates, algae, and macroscopic fungus.  **
**The definition of “botanical” is further extended to include botanical extracts and isolated bioactive constituents other than essential nutrients. **

## Examples of Botanical Ingredients in Dietary Supplements 

***  ***
***	***
**  ****  ****Phytomedicines****	**
**        ****St. John’s Wort, Valerian, Ginkgo **
**    ****	****	****	****	**
**    ****Foods **
**        ****Soy, Garlic, Green Tea, Blueberry**
***  ***
*** ***

## Bacterial or yeast fermentation products are not included. 

**Synthetic compounds derived from botanical sources are not encouraged as test materials for research conducted under this initiative.  If the applicant proposes to study synthetic compounds, their use must be scientifically justified.  **_**This RFA is not supportive of applications aimed at new drug discovery.**_

_**Excluded test materials**_

## Botanical Ingredients: Foods or Drugs(Intended Use)

**1.   FDA Regulation: Dietary supplements are not intended to diagnose, cure, mitigate, treat or prevent disease. **
**2.  NIH recognizes FDA regulations but research on botanicals, for the purpose of this RFA, is not necessarily bounded by the above constraints.  **

## Frequently Asked Questions

## Rationale for Selection of

- Test materials
- Biological Process
- Health Outcomes
- 4.  Theme

## RFA OD-04-002Purpose

**Promote interdisciplinary collaborative study of botanicals, particularly those that are found as ingredients in dietary supplements **
**Conduct research of high potential for being translated into practical benefits for human health**

## RFA OD-04-002	Objectives

**1.   Build collaborative research teams to **_**advance the basic science**_** to inform clinical studies:**
**Characterize chemical composition of botanicals and study biological effects to provide better predictions of safety and efficacy in humans**
**Expand research base with development and improvement of preclinical model systems**

## RFA OD-04-002	Objectives

**2.   Cultivate the use of contemporary technologies and innovative approaches**
**3.  Conduct Clinical Studies (optional)**

## Clinical Studies	

**Optional**
**Phase I or early Phase II**
** ****NCCAM Requirement: Review of Funded Projects (OCRA)**
***NCCAM Guidance Document (see RFA)  ***
**IND Clearance**
**Is an IND Required?**
**Questions addressed to FDA**
**See RFA for FDA contact**